Latest Advances

  • Condition: High- or Highest-Risk Non-Muscle Invasive Bladder Cancer
  • Journal: BMC cancer
  • Treatment Used: Non-Maintenance Intravesical Bacillus Calmette-Guérin Induction Therapy (NMIBC)
  • Number of Patients: 2669
  • Published —
This study investigated whether non-maintenance eight-dose induction Bacillus Calmette-Guérin (iBCG)BCG was comparable to six-dose induction Bacillus Calmette-Guérin plus maintenance Bacillus Calmette-Guérin (mBCG) in patients with high- or highest risk non-muscle invasive bladder cancer.
  • Condition: Bladder Cancer
  • Journal: Cancer biology & medicine
  • Treatment Used: Hyperthermic plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Treatment Alone
  • Number of Patients: 560
  • Published —
In this study, researchers compared the effectiveness of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone for the treatment of intermediate and high risk nonmuscle-invasive bladder cancer.
  • Condition: Bladder Cancer
  • Journal: In vivo (Athens, Greece)
  • Treatment Used: Pirarubicin
  • Number of Patients: 165
  • Published —
In this study, researchers evaluated the effectiveness of a single instillation of pirarubicin with a short retention time for preventing intravesical recurrence of low-risk non-muscle-invasive bladder cancer.
  • Condition: Bladder Tumor
  • Journal: Journal of cancer research and therapeutics
  • Treatment Used: Bipolar or Monopolar Transurethral Resection
  • Number of Patients: 1193
  • Published —
This study compared the clinical outcomes of using bipolar or monopolar transurethral resection to treat patients with bladder tumor.
  • Condition: Midline Incisional Hernia (MIH) After Radical Cystectomy for Bladder Cancer
  • Journal: PloS one
  • Treatment Used: Surgery
  • Number of Patients: 0
  • Published —
This study evaluated the surgical treatment of midline incisional hernia (MIH) after cystectomy (bladder removal) for bladder cancer.
  • Condition: Large Non-Muscle-Invasive Bladder Cancer
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Complete Transurethral Resection, Intravesical Pirarubicin
  • Number of Patients: 1
  • Published —
This case report describes a 69-year-old man diagnosed with a large non-muscle-invasive bladder cancer treated with complete transurethral resection and intravesical pirarubicin.
  • Condition: Early Gall Bladder Cancer
  • Journal: Journal of Nepal Health Research Council
  • Treatment Used: Laparoscopic Extended Cholecystectomy
  • Number of Patients: NULL
  • Published —
This study evaluated the outcomes of laparoscopic extended cholecystectomy (surgical procedure to remove your gallbladder) for patients with early gall bladder (small hollow organ where bile is stored and concentrated before it is released into the small intestine) cancer.
  • Condition: Colorectal Cancer with Bladder Invasion
  • Journal: Gan to kagaku ryoho. Cancer & chemotherapy
  • Treatment Used: Ileal Neobladder Reconstruction and Lower Anterior Resection plus Total Cystectomy
  • Number of Patients: 1
  • Published —
This case report describes a patient with colorectal cancer with bladder invasion.
  • Condition: Neuroendocrine Carcinoma of the Gallbladder
  • Journal: Gan to kagaku ryoho. Cancer & chemotherapy
  • Treatment Used: Chemotherapy and Radiation Therapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with neuroendocrine carcinoma of the gallbladder.
  • Condition: Bladder Cancer
  • Journal: Medicine
  • Treatment Used: Open, Laparoscopic, or Robot-Assisted Radical Cystectomy
  • Number of Patients: 6382
  • Published —
This study investigated the clinical outcomes of using an open, laparoscopic, or robot-assisted radical cystectomy to treat patients with bladder cancer.
  • Condition: High-Risk Nonmuscle Invasive Bladder Cancer
  • Journal: BMC urology
  • Treatment Used: Low-Dose Bacillus Calmette-Guerin (BCG) Tokyo Strain Intravesical Maintenance Therapy
  • Number of Patients: 78
  • Published —
This study tested the safety and efficacy of using a low-dose BCG Tokyo strain intravesical maintenance therapy to treat patients with high-risk nonmuscle invasive bladder cancer.
  • Condition: Primary Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Urinary Bladder
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Rituximab
  • Number of Patients: 1
  • Published —
This case report describes a patient with primary MALT lymphoma of the urinary bladder.
Showing 1-12 of 312